Biomarker Technologies Market Growing At A CAGR Of 13.2% And To Target $58.50 Billion By 2026

Biomarker Technologies

Growth in market is due to rise in R&D activities & surge in prevalence of diseases such as various types of cancer, diabetes type 1, AIDS, and others.

PORTLAND, OR, UNITED STATES, October 29, 2020 /EINPresswire.com/ — UPDATE AVAILABLE ON-DEMAND

The report on the global biomarker technologies market highlights that the market is expected to reach $21.59 billion by 2018, from $58.50 billion in 2026, growing at a CAGR of 13.2% from 2019 to 2026. The report offers the current market size and forecasts along with Porter’s Five Forces analysis to help market players, stakeholders, startups, and investors to determine the current scenario and take further steps for the future. Drivers and opportunities for highest revenue generating and fastest growing segments would help in tapping into specific segment to achieve growth. Moreover, regional analysis would assist in expansion strategies for the market players and startups.

The biomarker technologies report offers an in-depth analysis of the Covid-19 impact on various market segments and countries. Moreover, the report offers major market trends and forecasts, considering the Covid-19 situation.

To Get the Sample Copy of Report Visit @ https://www.alliedmarketresearch.com/request-sample/5293

Rise in prevalence of various diseases, surge in R&D activities in healthcare coupled with increase in adoption of early toxicity testing, advantages offered by biomarker in drug development, and rapid escalation in genome mapping programs drive the growth of the global biomarker technologies market. On the other hand, high initial capital investments required for biomarker discovery and lack of awareness regarding the use of biomarker technologies check the market growth to some extent. However, high potential of the emerging economies is expected to create lucrative opportunities for the key players in the industry.

The consumables segment to rule the roost-

Based on product, the consumables segment accounted for more than two-third of the total market segment in 2018 and is expected to maintain its dominance throughout the forecast period. This is attributed to the crucial role consumables play in biomarker testing. The instruments segment, on the other hand, is projected to grow at the fastest CAGR of 14.1% through 2019–2026.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/5293

The immunoassay segment to retain its top status during the study period-

Based on technology, the immunoassay segment contributed to nearly half of the total market share in 2018 and is anticipated to lead the trail during the estimated period. Rise in prevalence of various types of cancers such as breast cancer, prostate cancer and others has spurred the growth. At the same time, the next generation sequencing segment is predicted to cite the fastest CAGR of 15.1% till 2026.

North America to maintain its dominance through 2019–2026-

Based on geography, North America held more than two-fifth of the market share in 2018 and is anticipated to dominate during the period 2019–2026. Surge in R&D related to drug discovery, easy availability of instruments and consumables, availability of trained technicians, and high prevalence of diseases such as cancer and autoimmune diseases have augmented the growth. Simultaneously, the Asia-Pacific region would showcase the fastest CAGR of 14.8% till 2026.

Access Full Report @ https://www.alliedmarketresearch.com/biomarker-technologies-market

The major companies profiled are:

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Illumina, Inc.
• LI-COR, Inc.
• Merck KGAA
• PerkinElmer Inc.
• QIAGEN
• Shimadzu Corporation
• Thermo Fisher Scientific, Inc.

Similar Reports:

Forensic Technology Market Analysis and Industry Forecast, 2027

Electrophoresis Technology Market Analysis and Industry Forecast, 2027

Drug Delivery Technology Market Analysis and Industry Forecast, 2027

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire